Cindy Berthelot, MD
Dermatology · Houston, TXNPI 1114132099
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,920 of the $3,370 with a category attached, or 86.6%. 27 manufacturers reported payments, led by Galderma Laboratories, L.p. at 24.0% of the total. Reporting peaked in 2020 at $949 and has fallen 88.5% since, to $109 in 2025. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 171 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$810
- Sun Pharmaceutical Industries Inc.$671
- AbbVie$436
- Neurocrine Biosciences, Inc.$240
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$180
- Arcutis Biotherapeutics, Inc.$163
- plus $869 from 21 others
What the payments were for
- Speaking & faculty fees$45013%
- Food & beverage$2,92087%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 30 | $810 |
| Sun Pharmaceutical Industries Inc. | 36 | $671 |
| AbbVie(2 entities) | 28 | $436 |
| Neurocrine Biosciences, Inc. | 14 | $240 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $180 |
| Arcutis Biotherapeutics, Inc. | 8 | $163 |
| Pfizer | 8 | $157 |
| VYNE Pharmaceuticals Inc. | 6 | $102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $100 |
| LEO Pharma Inc. | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Organon | 2 | $45 |
| Almirall LLC | 2 | $40 |
| Dermira, Inc. | 2 | $39 |
| EPI Health, LLC | 2 | $32 |
| Journey Medical Corporation | 2 | $26 |
| Dermavant Sciences, Inc. | 1 | $23 |
| Mission Pharmacal Company | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Merz North America, Inc. | 1 | $20 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Sandoz | 1 | $15 |
| Merck | 1 | $13 |
How this compares
$3,370 in reported general payments places this provider in the 45th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 31 | $2,278 |
| Doxycycline Hyclate | 48 | $1,653 |
| Clobetasol Propionate | 30 | $1,523 |
| Metronidazole | 31 | $1,249 |
| Betamethasone Dipropionate | 33 | $819 |
| Mupirocin | 97 | $714 |
| ValacyclovirValacyclovir Hcl | 15 | $707 |
| Ketoconazole | 40 | $537 |
| Triamcinolone Acetonide | 43 | $438 |
| Clindamycin Phosphate | 13 | $237 |
| Hydrocortisone | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Houston
- Alpesh DesaiHouston$1.6M
- Geeta PatelHouston$575K
- Michael MigdenHouston$310K
- Catherine PapasakelariouHouston$289K
- Stephen MahoneyHouston$137K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.